Precision BioSciences Wins Patent Infringement Lawsuit Against Cellectis

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has won a patent infringement lawsuit against Cellectis SA. A jury in the United States District Court for the District of Delaware found that all of the claims of Cellectis’ U.S. Pat. No. 7,897,372 (“the ‘372 patent”) that were asserted against Precision are invalid and that Precision did not literally infringe the asserted claims.

Help employers find you! Check out all the jobs and post your resume.

Back to news